iShares Biotechnology ETF (NASDAQ:IBB) Position Boosted by Madrona Financial Services LLC

Madrona Financial Services LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 153.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 81,150 shares of the financial services provider’s stock after buying an additional 49,075 shares during the period. iShares Biotechnology ETF accounts for 2.9% of Madrona Financial Services LLC’s portfolio, making the stock its 10th biggest position. Madrona Financial Services LLC owned approximately 0.18% of iShares Biotechnology ETF worth $10,379,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in IBB. Sequoia Financial Advisors LLC lifted its position in iShares Biotechnology ETF by 14.9% during the first quarter. Sequoia Financial Advisors LLC now owns 3,684 shares of the financial services provider’s stock valued at $471,000 after buying an additional 479 shares during the period. SOL Capital Management CO increased its stake in shares of iShares Biotechnology ETF by 18.5% in the 1st quarter. SOL Capital Management CO now owns 37,880 shares of the financial services provider’s stock worth $4,845,000 after acquiring an additional 5,925 shares in the last quarter. Alpine Bank Wealth Management purchased a new position in iShares Biotechnology ETF during the 1st quarter valued at about $75,000. Golden State Wealth Management LLC boosted its stake in iShares Biotechnology ETF by 97.7% during the first quarter. Golden State Wealth Management LLC now owns 1,916 shares of the financial services provider’s stock worth $245,000 after acquiring an additional 947 shares in the last quarter. Finally, Global Assets Advisory LLC boosted its stake in iShares Biotechnology ETF by 255.6% during the first quarter. Global Assets Advisory LLC now owns 7,315 shares of the financial services provider’s stock worth $866,000 after acquiring an additional 5,258 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.6%

IBB stock opened at $126.69 on Thursday. The firm has a 50 day moving average price of $123.39 and a 200-day moving average price of $129.66. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $150.57.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.